amaxa biosystems
ResourcesFAQContactLegalSitemap 
Home
Research Areas
Products
Cell Database
Applications
Company
 

Resources

FAQ

FAQ - Complete List

Contact

Legal

Sitemap

My Account

 
You are not logged in. Log in
Home » FAQ » FAQ - Complete List

FAQ Database - Complete List

186 FAQ articles available.

 [1]  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  next

  1. What is the basic principle of the Nucleofector® technology?

  2. Why is the Nucleofector® technology ideal for primary cells and difficult-to-transfect cell lines?

  3. What optimization is necessary to get the technology to work?

  4. What can I do when my cell of interest is not in your range of products?

  5. What is the best way to establish the Nucleofector® technology in my lab?

  6. amaxa suggests using 4-5 million neural cells per 100µl nucleofection® reaction. Why is such a high cell number required? How can I perform nucleofections with fewer cells ?

  7. I'm transfecting neurons in a mixed glial culture. Is there an 'optimal' way to influence cell survival and select neurons after nucleofection®?

  8. Is there a special recommendation on Human T cell enrichment before nucleofection®?

  9. Are there any recommendations to avoid excessive mortality during T cell nucleofection®?

  10. How can I increase cell viability of Dendritic cells after nucleofection®?

 [1]  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  next

   
   
TOPImprintLegalFeedback© amaxa 2008-05-05Certifications